South Korean Pharmaceuticals & Biotech Most Popular Stocks

KUKJEON PHARMACEUTICAL

Market Cap: ₩163.2b

Operates as a chemical total solutions provider in South Korea.

DK Life Science

Market Cap: ₩162.5b

A pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.

NIBEC

Market Cap: ₩158.1b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Macrogen

Market Cap: ₩156.9b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

HANDOK

Market Cap: ₩157.3b

Operates as a pharmaceutical company.

Aprogen Biologics

Market Cap: ₩154.7b

Manufactures and sells pharmaceutical products primarily in South Korea.

Kyung Dong Pharmaceutical

Market Cap: ₩153.6b

Manufactures and sells pharmaceuticals in South Korea.

Jeil PharmaceuticalLtd

Market Cap: ₩152.3b

Develops and supplies pharmaceutical products primarily in South Korea.

HEM Pharma

Market Cap: ₩150.7b

Operates as a microbiome healthcare company in South Korea and internationally.

Onconic Therapeutics

Market Cap: ₩150.1b

Engages in the research and development of anti-cancer therapy in South Korea.

Daihan PharmaceuticalLtd

Market Cap: ₩148.5b

Engages in the manufacture and sale of therapeutic drugs in South Korea.

SAMSUNG PHARM

Market Cap: ₩148.4b

Manufactures and sells pharmaceutical products in South Korea.

Kyongbo Pharmaceutical

Market Cap: ₩148.0b

Manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally.

IMB Dx

Market Cap: ₩142.4b

Provides liquid biopsy platform in South Korea.

Inventage Lab

Market Cap: ₩141.4b

Inventage Lab Inc., a platform technology company, develops medicines using microfluidics based drug delivery systems.

DNA Link

Market Cap: ₩140.0b

A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

TegoScience

Market Cap: ₩134.6b

A biotechnology-based cosmetics company, engages in the production and sale of skin cell therapy products from human epithelial cells in South Korea.

DongKoo Bio & Pharma

Market Cap: ₩133.9b

Manufactures and sells pharmaceuticals in South Korea.

iNtRON Biotechnology

Market Cap: ₩130.8b

Engages in the development of novel drugs in South Korea.

Kangstem Biotech

Market Cap: ₩126.7b

A biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases.

PHARMARESEARCH BIO

Market Cap: ₩126.1b

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide.

MedPacto

Market Cap: ₩125.6b

A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.

Oncocross

Market Cap: ₩124.8b

Develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea.

BIO-FD&CLtd

Market Cap: ₩121.5b

Develops active ingredients for anti-aging cosmetics in South Korea.

Jeil Pharma Holdings

Market Cap: ₩113.6b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

HLB PANAGENE

Market Cap: ₩112.9b

Develops products in the field of molecular diagnostics in South Korea.

NanoEntek

Market Cap: ₩110.8b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

CKD Bio

Market Cap: ₩109.7b

Engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally.

Shaperon

Market Cap: ₩106.7b

A clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics.

Ilsung Is

Market Cap: ₩107.0b

Operates as a pharmaceutical company in South Korea.

Helixmith

Market Cap: ₩105.0b

Develops biologic and natural nutraceutical products.

Y-Biologics

Market Cap: ₩103.8b

An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.

Enzychem Lifesciences

Market Cap: ₩100.2b

Engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.

Theragen EtexLtd

Market Cap: ₩100.0b

Engages in the research and development, production, and sale of pharmaceutical products in Korea.

Daehan New Pharm

Market Cap: ₩99.7b

Manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.

Cytogen

Market Cap: ₩98.4b

A biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.